Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSCs in Compensated Hepatitis B Cirrhosis
NCT05507762Phase 2Unknown
- Sponsor
- Renmin Hospital of Wuhan University
- Start
- Jul 2021
- Primary completion
- Jul 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord derived mesenchymal stem cells, sponsored by Renmin Hospital of Wuhan University. Status: unknown.
02
Drugs
human umbilical cord derived mesenchymal stem cells
Beyond the preview
Go deeper on NCT05507762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05507762.